Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.

Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing.

Ogunniyi AD, Kopecki Z, Hickey EE, Khazandi M, Peel E, Belov K, Boileau A, Garg S, Venter H, Chan WY, Hill PB, Page SW, Cowin AJ, Trott DJ.

PLoS One. 2018 Jul 16;13(7):e0200195. doi: 10.1371/journal.pone.0200195. eCollection 2018.

2.

Adaptation and conservation insights from the koala genome.

Johnson RN, O'Meally D, Chen Z, Etherington GJ, Ho SYW, Nash WJ, Grueber CE, Cheng Y, Whittington CM, Dennison S, Peel E, Haerty W, O'Neill RJ, Colgan D, Russell TL, Alquezar-Planas DE, Attenbrow V, Bragg JG, Brandies PA, Chong AY, Deakin JE, Di Palma F, Duda Z, Eldridge MDB, Ewart KM, Hogg CJ, Frankham GJ, Georges A, Gillett AK, Govendir M, Greenwood AD, Hayakawa T, Helgen KM, Hobbs M, Holleley CE, Heider TN, Jones EA, King A, Madden D, Graves JAM, Morris KM, Neaves LE, Patel HR, Polkinghorne A, Renfree MB, Robin C, Salinas R, Tsangaras K, Waters PD, Waters SA, Wright B, Wilkins MR, Timms P, Belov K.

Nat Genet. 2018 Aug;50(8):1102-1111. doi: 10.1038/s41588-018-0153-5. Epub 2018 Jul 2.

PMID:
29967444
3.

Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells.

Fernandez-Rojo MA, Deplazes E, Pineda SS, Brust A, Marth T, Wilhelm P, Martel N, Ramm GA, Mancera RL, Alewood PF, Woods GM, Belov K, Miles JJ, King GF, Ikonomopoulou MP.

Cell Death Discov. 2018 Feb 14;4:19. doi: 10.1038/s41420-018-0030-0. eCollection 2018 Dec.

4.

MHC diversity and female age underpin reproductive success in an Australian icon; the Tasmanian Devil.

Russell T, Lisovski S, Olsson M, Brown G, Spindler R, Lane A, Keeley T, Hibbard C, Hogg CJ, Thomas F, Belov K, Ujvari B, Madsen T.

Sci Rep. 2018 Mar 8;8(1):4175. doi: 10.1038/s41598-018-20934-9.

5.

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.

Pye R, Patchett A, McLennan E, Thomson R, Carver S, Fox S, Pemberton D, Kreiss A, Baz Morelli A, Silva A, Pearse MJ, Corcoran LM, Belov K, Hogg CJ, Woods GM, Lyons AB.

Front Immunol. 2018 Feb 19;9:259. doi: 10.3389/fimmu.2018.00259. eCollection 2018.

6.

Transcriptomic changes in the pre-implantation uterus highlight histotrophic nutrition of the developing marsupial embryo.

Whittington CM, O'Meally D, Laird MK, Belov K, Thompson MB, McAllan BM.

Sci Rep. 2018 Feb 5;8(1):2412. doi: 10.1038/s41598-018-20744-z.

7.

Koala immunology and infectious diseases: How much can the koala bear?

Madden D, Whaite A, Jones E, Belov K, Timms P, Polkinghorne A.

Dev Comp Immunol. 2018 May;82:177-185. doi: 10.1016/j.dci.2018.01.017. Epub 2018 Jan 31. Review.

PMID:
29382557
8.

Long-read genome sequence assembly provides insight into ongoing retroviral invasion of the koala germline.

Hobbs M, King A, Salinas R, Chen Z, Tsangaras K, Greenwood AD, Johnson RN, Belov K, Wilkins MR, Timms P.

Sci Rep. 2017 Nov 20;7(1):15838. doi: 10.1038/s41598-017-16171-1.

9.

Marsupial and monotreme cathelicidins display antimicrobial activity, including against methicillin-resistant Staphylococcus aureus.

Peel E, Cheng Y, Djordjevic JT, Kuhn M, Sorrell T, Belov K.

Microbiology. 2017 Oct;163(10):1457-1465. doi: 10.1099/mic.0.000536. Epub 2017 Sep 27.

PMID:
28949902
10.

Characterisation of MHC class I genes in the koala.

Cheng Y, Polkinghorne A, Gillett A, Jones EA, O'Meally D, Timms P, Belov K.

Immunogenetics. 2018 Feb;70(2):125-133. doi: 10.1007/s00251-017-1018-2. Epub 2017 Jul 1.

PMID:
28669101
11.

Increasing generations in captivity is associated with increased vulnerability of Tasmanian devils to vehicle strike following release to the wild.

Grueber CE, Reid-Wainscoat EE, Fox S, Belov K, Shier DM, Hogg CJ, Pemberton D.

Sci Rep. 2017 May 19;7(1):2161. doi: 10.1038/s41598-017-02273-3.

12.

No evidence of inbreeding depression in a Tasmanian devil insurance population despite significant variation in inbreeding.

Gooley R, Hogg CJ, Belov K, Grueber CE.

Sci Rep. 2017 May 12;7(1):1830. doi: 10.1038/s41598-017-02000-y.

13.

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association.

Wright B, Willet CE, Hamede R, Jones M, Belov K, Wade CM.

Sci Rep. 2017 Mar 24;7(1):423. doi: 10.1038/s41598-017-00439-7.

14.

Antimicrobial Protection of Marsupial Pouch Young.

Cheng Y, Belov K.

Front Microbiol. 2017 Mar 7;8:354. doi: 10.3389/fmicb.2017.00354. eCollection 2017. Review.

15.

Significant decline in anticancer immune capacity during puberty in the Tasmanian devil.

Cheng Y, Heasman K, Peck S, Peel E, Gooley RM, Papenfuss AT, Hogg CJ, Belov K.

Sci Rep. 2017 Mar 16;7:44716. doi: 10.1038/srep44716.

16.

The Regulation of Uterine Proinflammatory Gene Expression during Pregnancy in the Live-Bearing Lizard, Pseudemoia entrecasteauxii.

Hendrawan K, Whittington CM, Brandley MC, Belov K, Thompson MB.

J Exp Zool B Mol Dev Evol. 2017 Jun;328(4):334-346. doi: 10.1002/jez.b.22733. Epub 2017 Mar 10. Erratum in: J Exp Zool B Mol Dev Evol. 2017 Sep;328(6):587.

PMID:
28296138
17.

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.

Tovar C, Pye RJ, Kreiss A, Cheng Y, Brown GK, Darby J, Malley RC, Siddle HV, Skjødt K, Kaufman J, Silva A, Baz Morelli A, Papenfuss AT, Corcoran LM, Murphy JM, Pearse MJ, Belov K, Lyons AB, Woods GM.

Sci Rep. 2017 Mar 9;7:43827. doi: 10.1038/srep43827.

18.

Immune-endocrine interactions in marsupials and monotremes.

Peel E, Belov K.

Gen Comp Endocrinol. 2017 Apr 1;244:178-185. doi: 10.1016/j.ygcen.2017.01.026. Epub 2017 Jan 27. Review.

PMID:
28132863
19.

Characterization of the antimicrobial peptide family defensins in the Tasmanian devil (Sarcophilus harrisii), koala (Phascolarctos cinereus), and tammar wallaby (Macropus eugenii).

Jones EA, Cheng Y, O'Meally D, Belov K.

Immunogenetics. 2017 Mar;69(3):133-143. doi: 10.1007/s00251-016-0959-1. Epub 2016 Nov 12.

PMID:
27838759

Supplemental Content

Loading ...
Support Center